Access cutting-edge oropharyngeal cancer treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access oropharyngeal cancer specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related oropharyngeal cancer treatment provided free
The purpose of this study is to determine whether treatment of HPV-related oropharyngeal squamous cell carcinoma in patients with undetectable postoperative HPV circulating tumor DNA (cfHPVDNA) with transoral robotic surgery (TORS) alone can result in cancer control and survival comparable to those previously reported with standard therapy. The protocol includes patients with only with low or intermediate pathologic risk factors following surgery with detectable pre-surgery cfHPVDNA and undetect
Sponsor: Icahn School of Medicine at Mount Sinai
Check if you qualify for this oropharyngeal cancer clinical trial in New York, NY
If you're searching for oropharyngeal cancer treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced oropharyngeal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.